Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001395064-21-000206
Filing Date
2021-10-18
Accepted
2021-10-18 06:03:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga-101821.htm SC 13G/A 64798
2 EX-99.1 exhibit991_101821.htm EX-99.1 1987
  Complete submission text file 0001395064-21-000206.txt   68418
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90744 | Film No.: 211327238
SIC: 2836 Biological Products, (No Diagnostic Substances)